default author photo

Xue Li

The University of Hong Kong - Centre for Safe Medication Practice and Research

SCHOLARLY PAPERS

4

DOWNLOADS

305

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

Self-Reported Reactogenicity of CoronaVac (Sinovac) Compared with Comirnaty (Pfizer-BioNTech): A Prospective Cohort Study with Intensive Monitoring

Number of pages: 16 Posted: 13 Nov 2021
The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong, The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong - Centre for Safe Medication Practice and Research, Hong Kong Science and Technology Park - Laboratory of Data Discovery for Health (D24H), The University of Hong Kong, The University of Hong Kong - Department of Family Medicine and Primary Care, Hong Kong Special Administration Region Government - Department of Health, Hong Kong Special Administration Region Government - Department of Health, The University of Hong Kong - WHO Collaborating Centre for Infectious Disease Epidemiology and Control, The University of Hong Kong - Centre for Safe Medication Practice and Research and The University of Hong Kong - Centre for Safe Medication Practice and Research
Downloads 95 (715,072)

Abstract:

Loading...

Community vaccination center, Covid-19, Pain, SARS-CoV-2, Self-reported adverse reactions, Severe allergic reactions, Systemic reactions

2.

Post-COVID-19 Multimorbidity Incidence by Prior Vaccination Status In People with One Pre-Existing Condition: A Population-Based Cohort Study Of Over One Million Individuals

Number of pages: 20 Posted: 23 Apr 2025
The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong - School of Clinical Medicine, The University of Hong Kong, The University of Hong Kong - Centre for Safe Medication Practice and Research, Hong Kong Science and Technology Park - Laboratory of Data Discovery for Health (D24H), The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong and The University of Hong Kong
Downloads 80 (803,225)

Abstract:

Loading...

Multimorbidity, COVID-19, Long-COVID, Vaccination, Public Health, Primary Health Care

3.

Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis

Number of pages: 40 Posted: 12 Jul 2022
The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong - Centre for Safe Medication Practice and Research, University of South Australia - Quality Use of Medicines and Pharmacy Research Center, University of Cincinnati - Department of Pharmacy, University of South Australia - Quality Use of Medicines and Pharmacy Research Center, University of South Australia - Quality Use of Medicines and Pharmacy Research Center, University of South Australia - Quality Use of Medicines and Pharmacy Research Center, National Cheng Kung University - Institute of Clinical Pharmacy and Pharmaceutical Sciences, Sungkyunkwan University - Department of Biohealth Regulatory Science, The University of Hong Kong - Department of Medicine, The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong - Department of Medicine, Tianjin University - School of Pharmaceutical Science and Technology, The University of Hong Kong - Queen Mary Hospital, The University of Hong Kong - Department of Medicine, The University of Hong Kong - Department of Medicine, The University of Hong Kong - Centre for Safe Medication Practice and Research and The University of Hong Kong - Centre for Safe Medication Practice and Research
Downloads 75 (844,901)
Citation 1

Abstract:

Loading...

Biosimilar, Interrupted Time-Series Analysis, Quasi experiment, Infliximab, Consumption, Listed Price, Drug policy, Economics

4.

Effects of Sequential Versus Single Pneumococcal Vaccination on Cardiovascular Diseases Among Older Adults: A Population-Based Cohort Study

Number of pages: 25 Posted: 24 Mar 2023
The University of Hong Kong - Department of Medicine, The University of Hong Kong - Department of Pharmacology and Pharmacy, The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong - Department of Pharmacology and Pharmacy, London School of Hygiene & Tropical Medicine, The University of Hong Kong - Department of Pharmacology and Pharmacy, The University of Hong Kong - Division of Geriatrics, New York University (NYU), The University of Hong Kong - School of Clinical Medicine, The University of Hong Kong - Cardiology Division and The University of Hong Kong - Centre for Safe Medication Practice and Research
Downloads 55 (1,010,164)

Abstract:

Loading...

penumococcal vaccine strategy, vaccine benefits, cardiovascular disease, population-based retrospective cohort study, healthcare big data, real-world evidence, geriatrics